Wearable Injectors Market to 2027 - Global Analysis and Forecasts By Type (On Body Injectors and Off Body Injectors), Application (Diabetes, Oncology, Cardiovascular Disease, Autoimmune Disease, and Other Applications),End User (Hospitals, Clinics, Home Healthcare, and Other End Users) and Geography
Report Code: TIPMD00002677 No. of Pages: 150 Category: Medical Device Status: Upcoming
Wearable injectors are the innovative injection systems that are designed to automatically deliver high-volume and/or highly viscous biotech drugs subcutaneously. These devices can be used in in clinics as well as homecare. Wearable injectors help in making the process of drugs delivery more convenient to the patients. Due to the easy of drug administration, the devices are being preferred over the traditional methods of drug delivery.
Increasing prevalence of chronic diseases, such as diabetes and hypertension is anticipated to fuel the growth of wearable injectors market during the forecast period. In addition, the availability of reimbursements for the use of these devices is expected to offer growth opportunities in the market in the coming years.
The "Global Wearable Injectors Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global market with detailed market segmentation by type, application, end user, and geography. The global wearable injectors market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The global wearable injectors market is segmented on the basis of type is segmented as, on body injectors and off body injectors. On the basis of application, the market is classified as, diabetes, oncology, cardiovascular disease, autoimmune disease, and other applications. The wearable injectors market is classified based on end user as, hospitals, clinics, home healthcare, and other end users.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global wearable injectors market based on type, application and end user. It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The wearable injectors market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America is expected to contribute to the largest share in the wearable injectors market in the coming years, owing to the technological advancements in insulin delivery systems in the region. Asia Pacific is expected to witness significant growth during the forecast period, owing increasing prevalence in chronic disorders, such as diabetes hypertension as well as cancer.
The report analyzes factors affecting wearable injectors market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the wearable injectors market in these regions.
The report also includes the profiles of key wearable injectors manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the wearable injectors market include, BD, CeQur SA, Debiotech S.A., E3D Elcam Drug Delivery Devices, Insulet Corporation, Sensile Medical AG, Tandem Diabetes Care, Inc., Valeritas, Inc, West Pharmaceutical Services, Inc., and Ypsomed AG among others.
Increasing prevalence of chronic diseases, such as diabetes and hypertension is anticipated to fuel the growth of wearable injectors market during the forecast period. In addition, the availability of reimbursements for the use of these devices is expected to offer growth opportunities in the market in the coming years.
The "Global Wearable Injectors Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global market with detailed market segmentation by type, application, end user, and geography. The global wearable injectors market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The global wearable injectors market is segmented on the basis of type is segmented as, on body injectors and off body injectors. On the basis of application, the market is classified as, diabetes, oncology, cardiovascular disease, autoimmune disease, and other applications. The wearable injectors market is classified based on end user as, hospitals, clinics, home healthcare, and other end users.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global wearable injectors market based on type, application and end user. It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The wearable injectors market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America is expected to contribute to the largest share in the wearable injectors market in the coming years, owing to the technological advancements in insulin delivery systems in the region. Asia Pacific is expected to witness significant growth during the forecast period, owing increasing prevalence in chronic disorders, such as diabetes hypertension as well as cancer.
The report analyzes factors affecting wearable injectors market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the wearable injectors market in these regions.
The report also includes the profiles of key wearable injectors manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the wearable injectors market include, BD, CeQur SA, Debiotech S.A., E3D Elcam Drug Delivery Devices, Insulet Corporation, Sensile Medical AG, Tandem Diabetes Care, Inc., Valeritas, Inc, West Pharmaceutical Services, Inc., and Ypsomed AG among others.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. KEY TAKEAWAYS
3. WEARABLE INJECTORS MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Wearable Injectors Market - By Type
3.2.2. Wearable Injectors Market - By Application
3.2.3. Wearable Injectors Market - By End User
3.2.4. Wearable Injectors Market - By Region
3.2.4.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis
4. WEARABLE INJECTORS MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS
5. WEARABLE INJECTORS MARKET - GLOBAL ANALYSIS
5.1. GLOBAL WEARABLE INJECTORS MARKET OVERVIEW
5.2. GLOBAL WEARABLE INJECTORS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. PERFORMANCE OF KEY PLAYERS
5.4. EXPERT OPINIONS
6. WEARABLE INJECTORS MARKET REVENUE AND FORECASTS TO 2027 - BY TYPE
6.1. OVERVIEW
6.2. TYPE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. ON BODY INJECTORS MARKET
6.3.1. Overview
6.3.2. On Body Injectors Market Revenue Forecasts and Analysis (US$ Mn)
6.4. OFF BODY INJECTORS MARKET
6.4.1. Overview
6.4.2. Off Body Injectors Market Revenue Forecasts and Analysis (US$ Mn)
7. WEARABLE INJECTORS MARKET REVENUE AND FORECASTS TO 2027 - BY APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. DIABETES MARKET
7.3.1. Overview
7.3.2. Diabetes Market Revenue Forecasts and Analysis (US$ Mn)
7.4. ONCOLOGY MARKET
7.4.1. Overview
7.4.2. Oncology Market Revenue Forecasts and Analysis (US$ Mn)
7.5. CARDIOVASCULAR DISEASE MARKET
7.5.1. Overview
7.5.2. Cardiovascular Disease Market Revenue Forecasts and Analysis (US$ Mn)
7.6. AUTOIMMUNE DISEASE MARKET
7.6.1. Overview
7.6.2. Autoimmune Disease Market Revenue Forecasts and Analysis (US$ Mn)
7.7. OTHER APPLICATIONS MARKET
7.7.1. Overview
7.7.2. Other Applications Market Revenue Forecasts and Analysis (US$ Mn)
8. WEARABLE INJECTORS MARKET REVENUE AND FORECASTS TO 2027 - BY END USER
8.1. OVERVIEW
8.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. HOSPITALS MARKET
8.3.1. Overview
8.3.2. Hospitals Market Revenue Forecasts and Analysis (US$ Mn)
8.4. CLINICS MARKET
8.4.1. Overview
8.4.2. Clinics Market Revenue Forecasts and Analysis (US$ Mn)
8.5. HOME HEALTHCARE MARKET
8.5.1. Overview
8.5.2. Home Healthcare Market Revenue Forecasts and Analysis (US$ Mn)
8.6. OTHER END USERS MARKET
8.6.1. Overview
8.6.2. Other End Users Market Revenue Forecasts and Analysis (US$ Mn)
9. NORTH AMERICA WEARABLE INJECTORS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
9.1. NORTH AMERICA WEARABLE INJECTORS MARKET OVERVIEW
9.2. NORTH AMERICA WEARABLE INJECTORS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. NORTH AMERICA WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
9.4. NORTH AMERICA WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
9.5. NORTH AMERICA WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
9.6. NORTH AMERICA WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
9.7. US MARKET OVERVIEW
9.7.1. US Wearable Injectors Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.7.2. US Wearable Injectors Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.7.3. US Wearable Injectors Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.8. CANADA MARKET OVERVIEW
9.8.1. Canada Wearable Injectors Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.8.2. Canada Wearable Injectors Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.8.3. Canada Wearable Injectors Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.9. MEXICO MARKET OVERVIEW
9.9.1. Mexico Wearable Injectors Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.9.2. Mexico Wearable Injectors Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.9.3. Mexico Wearable Injectors Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10. EUROPE WEARABLE INJECTORS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
10.1. EUROPE WEARABLE INJECTORS MARKET OVERVIEW
10.2. EUROPE WEARABLE INJECTORS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. EUROPE WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
10.4. EUROPE WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
10.5. EUROPE WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
10.6. EUROPE WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
10.7. UK MARKET OVERVIEW
10.7.1. UK Wearable Injectors Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.7.2. UK Wearable Injectors Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.7.3. UK Wearable Injectors Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.8. GERMANY MARKET OVERVIEW
10.8.1. Germany Wearable Injectors Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.8.2. Germany Wearable Injectors Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.8.3. Germany Wearable Injectors Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.9. FRANCE MARKET OVERVIEW
10.9.1. France Wearable Injectors Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.9.2. France Wearable Injectors Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.9.3. France Wearable Injectors Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11. ASIA PACIFIC WEARABLE INJECTORS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
11.1. ASIA PACIFIC WEARABLE INJECTORS MARKET OVERVIEW
11.2. ASIA PACIFIC WEARABLE INJECTORS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. ASIA PACIFIC WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
11.4. ASIA PACIFIC WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
11.5. ASIA PACIFIC WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
11.6. ASIA PACIFIC WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.7. CHINA MARKET OVERVIEW
11.7.1. China Wearable Injectors Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.7.2. China Wearable Injectors Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.7.3. China Wearable Injectors Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.8. JAPAN MARKET OVERVIEW
11.8.1. Japan Wearable Injectors Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.8.2. Japan Wearable Injectors Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.8.3. Japan Wearable Injectors Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.9. INDIA MARKET OVERVIEW
11.9.1. India Wearable Injectors Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.9.2. India Wearable Injectors Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.9.3. India Wearable Injectors Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12. MIDDLE EAST AND AFRICA (MEA) WEARABLE INJECTORS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
12.1. MIDDLE EAST AND AFRICA (MEA) WEARABLE INJECTORS MARKET OVERVIEW
12.2. MIDDLE EAST AND AFRICA (MEA) WEARABLE INJECTORS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. MIDDLE EAST AND AFRICA (MEA) WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
12.4. MIDDLE EAST AND AFRICA (MEA) WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
12.5. MIDDLE EAST AND AFRICA (MEA) WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
12.6. MIDDLE EAST AND AFRICA (MEA) WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
12.7. UAE MARKET OVERVIEW
12.7.1. UAE Wearable Injectors Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.7.2. UAE Wearable Injectors Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.7.3. UAE Wearable Injectors Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.8. SOUTH AFRICA MARKET OVERVIEW
12.8.1. South Africa Wearable Injectors Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.8.2. South Africa Wearable Injectors Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.8.3. South Africa Wearable Injectors Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.9. SAUDA ARABIA MARKET OVERVIEW
12.9.1. Saudi Arabia Wearable Injectors Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.9.2. Saudi Arabia Wearable Injectors Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.9.3. Saudi Arabia Wearable Injectors Market Revenue Forecasts and Analysis - By End User (US$ Mn)
13. SOUTH AND CENTRAL AMERICA WEARABLE INJECTORS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
13.1. SOUTH AND CENTRAL AMERICA WEARABLE INJECTORS MARKET OVERVIEW
13.2. SOUTH AND CENTRAL AMERICA WEARABLE INJECTORS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.3. SOUTH AND CENTRAL AMERICA WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
13.4. SOUTH AND CENTRAL AMERICA WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
13.5. SOUTH AND CENTRAL AMERICA WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
13.6. SOUTH AND CENTRAL AMERICA WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
13.7. BRAZIL MARKET OVERVIEW
13.7.1. Brazil Wearable Injectors Market Revenue Forecasts and Analysis - By Type (US$ Mn)
13.7.2. Brazil Wearable Injectors Market Revenue Forecasts and Analysis - By Application (US$ Mn)
13.7.3. Brazil Wearable Injectors Market Revenue Forecasts and Analysis - By End User (US$ Mn)
14. INDUSTRY LANDSCAPE
14.1. ORGANIC GROWTH STRATEGIES
14.1.1. New Product Launches
14.1.2. Marketing & Promotional Activities
14.2. INORGANIC GROWTH STRATEGIES
14.2.1. Partnerships, Collaborations, and Joint Ventures
14.2.2. Mergers & Acquisitions
15. WEARABLE INJECTORS MARKET, KEY COMPANY PROFILES
15.1. BD
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Financial Overview
15.1.4. Product Portfolio
15.1.5. SWOT Analysis
15.1.6. Key Developments
15.2. CEQUR SA
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Financial Overview
15.2.4. Product Portfolio
15.2.5. SWOT Analysis
15.2.6. Key Developments
15.3. DEBIOTECH S.A.
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Financial Overview
15.3.4. Product Portfolio
15.3.5. SWOT Analysis
15.3.6. Key Developments
15.4. E3D ELCAM DRUG DELIVERY DEVICES
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Financial Overview
15.4.4. Product Portfolio
15.4.5. SWOT Analysis
15.4.6. Key Developments
15.5. INSULET CORPORATION
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Financial Overview
15.5.4. Product Portfolio
15.5.5. SWOT Analysis
15.5.6. Key Developments
15.6. SENSILE MEDICAL AG
15.6.1. Business Description
15.6.2. Financial Overview
15.6.3. Product Portfolio
15.6.4. SWOT Analysis
15.6.5. Key Developments
15.7. TANDEM DIABETES CARE, INC.
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Financial Overview
15.7.4. Product Portfolio
15.7.5. SWOT Analysis
15.7.6. Key Developments
15.8. VALERITAS, INC
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Financial Overview
15.8.4. Product Portfolio
15.8.5. SWOT Analysis
15.8.6. Key Developments
15.9. WEST PHARMACEUTICAL SERVICES, INC.
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Financial Overview
15.9.4. Product Portfolio
15.9.5. SWOT Analysis
15.9.6. Key Developments
15.10. YPSOMED AG
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Financial Overview
15.10.4. Product Portfolio
15.10.5. SWOT Analysis
15.10.6. Key Developments
16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
16.3. RESEARCH METHODOLOGY
1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. KEY TAKEAWAYS
3. WEARABLE INJECTORS MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Wearable Injectors Market - By Type
3.2.2. Wearable Injectors Market - By Application
3.2.3. Wearable Injectors Market - By End User
3.2.4. Wearable Injectors Market - By Region
3.2.4.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis
4. WEARABLE INJECTORS MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS
5. WEARABLE INJECTORS MARKET - GLOBAL ANALYSIS
5.1. GLOBAL WEARABLE INJECTORS MARKET OVERVIEW
5.2. GLOBAL WEARABLE INJECTORS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. PERFORMANCE OF KEY PLAYERS
5.4. EXPERT OPINIONS
6. WEARABLE INJECTORS MARKET REVENUE AND FORECASTS TO 2027 - BY TYPE
6.1. OVERVIEW
6.2. TYPE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. ON BODY INJECTORS MARKET
6.3.1. Overview
6.3.2. On Body Injectors Market Revenue Forecasts and Analysis (US$ Mn)
6.4. OFF BODY INJECTORS MARKET
6.4.1. Overview
6.4.2. Off Body Injectors Market Revenue Forecasts and Analysis (US$ Mn)
7. WEARABLE INJECTORS MARKET REVENUE AND FORECASTS TO 2027 - BY APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. DIABETES MARKET
7.3.1. Overview
7.3.2. Diabetes Market Revenue Forecasts and Analysis (US$ Mn)
7.4. ONCOLOGY MARKET
7.4.1. Overview
7.4.2. Oncology Market Revenue Forecasts and Analysis (US$ Mn)
7.5. CARDIOVASCULAR DISEASE MARKET
7.5.1. Overview
7.5.2. Cardiovascular Disease Market Revenue Forecasts and Analysis (US$ Mn)
7.6. AUTOIMMUNE DISEASE MARKET
7.6.1. Overview
7.6.2. Autoimmune Disease Market Revenue Forecasts and Analysis (US$ Mn)
7.7. OTHER APPLICATIONS MARKET
7.7.1. Overview
7.7.2. Other Applications Market Revenue Forecasts and Analysis (US$ Mn)
8. WEARABLE INJECTORS MARKET REVENUE AND FORECASTS TO 2027 - BY END USER
8.1. OVERVIEW
8.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. HOSPITALS MARKET
8.3.1. Overview
8.3.2. Hospitals Market Revenue Forecasts and Analysis (US$ Mn)
8.4. CLINICS MARKET
8.4.1. Overview
8.4.2. Clinics Market Revenue Forecasts and Analysis (US$ Mn)
8.5. HOME HEALTHCARE MARKET
8.5.1. Overview
8.5.2. Home Healthcare Market Revenue Forecasts and Analysis (US$ Mn)
8.6. OTHER END USERS MARKET
8.6.1. Overview
8.6.2. Other End Users Market Revenue Forecasts and Analysis (US$ Mn)
9. NORTH AMERICA WEARABLE INJECTORS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
9.1. NORTH AMERICA WEARABLE INJECTORS MARKET OVERVIEW
9.2. NORTH AMERICA WEARABLE INJECTORS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. NORTH AMERICA WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
9.4. NORTH AMERICA WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
9.5. NORTH AMERICA WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
9.6. NORTH AMERICA WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
9.7. US MARKET OVERVIEW
9.7.1. US Wearable Injectors Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.7.2. US Wearable Injectors Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.7.3. US Wearable Injectors Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.8. CANADA MARKET OVERVIEW
9.8.1. Canada Wearable Injectors Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.8.2. Canada Wearable Injectors Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.8.3. Canada Wearable Injectors Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.9. MEXICO MARKET OVERVIEW
9.9.1. Mexico Wearable Injectors Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.9.2. Mexico Wearable Injectors Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.9.3. Mexico Wearable Injectors Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10. EUROPE WEARABLE INJECTORS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
10.1. EUROPE WEARABLE INJECTORS MARKET OVERVIEW
10.2. EUROPE WEARABLE INJECTORS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. EUROPE WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
10.4. EUROPE WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
10.5. EUROPE WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
10.6. EUROPE WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
10.7. UK MARKET OVERVIEW
10.7.1. UK Wearable Injectors Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.7.2. UK Wearable Injectors Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.7.3. UK Wearable Injectors Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.8. GERMANY MARKET OVERVIEW
10.8.1. Germany Wearable Injectors Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.8.2. Germany Wearable Injectors Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.8.3. Germany Wearable Injectors Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.9. FRANCE MARKET OVERVIEW
10.9.1. France Wearable Injectors Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.9.2. France Wearable Injectors Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.9.3. France Wearable Injectors Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11. ASIA PACIFIC WEARABLE INJECTORS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
11.1. ASIA PACIFIC WEARABLE INJECTORS MARKET OVERVIEW
11.2. ASIA PACIFIC WEARABLE INJECTORS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. ASIA PACIFIC WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
11.4. ASIA PACIFIC WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
11.5. ASIA PACIFIC WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
11.6. ASIA PACIFIC WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.7. CHINA MARKET OVERVIEW
11.7.1. China Wearable Injectors Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.7.2. China Wearable Injectors Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.7.3. China Wearable Injectors Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.8. JAPAN MARKET OVERVIEW
11.8.1. Japan Wearable Injectors Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.8.2. Japan Wearable Injectors Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.8.3. Japan Wearable Injectors Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.9. INDIA MARKET OVERVIEW
11.9.1. India Wearable Injectors Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.9.2. India Wearable Injectors Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.9.3. India Wearable Injectors Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12. MIDDLE EAST AND AFRICA (MEA) WEARABLE INJECTORS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
12.1. MIDDLE EAST AND AFRICA (MEA) WEARABLE INJECTORS MARKET OVERVIEW
12.2. MIDDLE EAST AND AFRICA (MEA) WEARABLE INJECTORS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. MIDDLE EAST AND AFRICA (MEA) WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
12.4. MIDDLE EAST AND AFRICA (MEA) WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
12.5. MIDDLE EAST AND AFRICA (MEA) WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
12.6. MIDDLE EAST AND AFRICA (MEA) WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
12.7. UAE MARKET OVERVIEW
12.7.1. UAE Wearable Injectors Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.7.2. UAE Wearable Injectors Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.7.3. UAE Wearable Injectors Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.8. SOUTH AFRICA MARKET OVERVIEW
12.8.1. South Africa Wearable Injectors Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.8.2. South Africa Wearable Injectors Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.8.3. South Africa Wearable Injectors Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.9. SAUDA ARABIA MARKET OVERVIEW
12.9.1. Saudi Arabia Wearable Injectors Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.9.2. Saudi Arabia Wearable Injectors Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.9.3. Saudi Arabia Wearable Injectors Market Revenue Forecasts and Analysis - By End User (US$ Mn)
13. SOUTH AND CENTRAL AMERICA WEARABLE INJECTORS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
13.1. SOUTH AND CENTRAL AMERICA WEARABLE INJECTORS MARKET OVERVIEW
13.2. SOUTH AND CENTRAL AMERICA WEARABLE INJECTORS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.3. SOUTH AND CENTRAL AMERICA WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
13.4. SOUTH AND CENTRAL AMERICA WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
13.5. SOUTH AND CENTRAL AMERICA WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
13.6. SOUTH AND CENTRAL AMERICA WEARABLE INJECTORS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
13.7. BRAZIL MARKET OVERVIEW
13.7.1. Brazil Wearable Injectors Market Revenue Forecasts and Analysis - By Type (US$ Mn)
13.7.2. Brazil Wearable Injectors Market Revenue Forecasts and Analysis - By Application (US$ Mn)
13.7.3. Brazil Wearable Injectors Market Revenue Forecasts and Analysis - By End User (US$ Mn)
14. INDUSTRY LANDSCAPE
14.1. ORGANIC GROWTH STRATEGIES
14.1.1. New Product Launches
14.1.2. Marketing & Promotional Activities
14.2. INORGANIC GROWTH STRATEGIES
14.2.1. Partnerships, Collaborations, and Joint Ventures
14.2.2. Mergers & Acquisitions
15. WEARABLE INJECTORS MARKET, KEY COMPANY PROFILES
15.1. BD
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Financial Overview
15.1.4. Product Portfolio
15.1.5. SWOT Analysis
15.1.6. Key Developments
15.2. CEQUR SA
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Financial Overview
15.2.4. Product Portfolio
15.2.5. SWOT Analysis
15.2.6. Key Developments
15.3. DEBIOTECH S.A.
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Financial Overview
15.3.4. Product Portfolio
15.3.5. SWOT Analysis
15.3.6. Key Developments
15.4. E3D ELCAM DRUG DELIVERY DEVICES
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Financial Overview
15.4.4. Product Portfolio
15.4.5. SWOT Analysis
15.4.6. Key Developments
15.5. INSULET CORPORATION
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Financial Overview
15.5.4. Product Portfolio
15.5.5. SWOT Analysis
15.5.6. Key Developments
15.6. SENSILE MEDICAL AG
15.6.1. Business Description
15.6.2. Financial Overview
15.6.3. Product Portfolio
15.6.4. SWOT Analysis
15.6.5. Key Developments
15.7. TANDEM DIABETES CARE, INC.
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Financial Overview
15.7.4. Product Portfolio
15.7.5. SWOT Analysis
15.7.6. Key Developments
15.8. VALERITAS, INC
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Financial Overview
15.8.4. Product Portfolio
15.8.5. SWOT Analysis
15.8.6. Key Developments
15.9. WEST PHARMACEUTICAL SERVICES, INC.
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Financial Overview
15.9.4. Product Portfolio
15.9.5. SWOT Analysis
15.9.6. Key Developments
15.10. YPSOMED AG
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Financial Overview
15.10.4. Product Portfolio
15.10.5. SWOT Analysis
15.10.6. Key Developments
16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
16.3. RESEARCH METHODOLOGY
The List of Companies
1. BD
2. CeQur SA
3. Debiotech S.A.
4. E3D Elcam Drug Delivery Devices
5. Insulet Corporation
6. Sensile Medical AG
7. Tandem Diabetes Care, Inc.
8. Valeritas, Inc
9. West Pharmaceutical Services, Inc.
10. Ypsomed AG
1. BD
2. CeQur SA
3. Debiotech S.A.
4. E3D Elcam Drug Delivery Devices
5. Insulet Corporation
6. Sensile Medical AG
7. Tandem Diabetes Care, Inc.
8. Valeritas, Inc
9. West Pharmaceutical Services, Inc.
10. Ypsomed AG